Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11114411PMC
http://dx.doi.org/10.1002/pcn5.32DOI Listing

Publication Analysis

Top Keywords

low-dose benzodiazepine
4
benzodiazepine receptor
4
receptor agonists
4
agonists completely
4
completely replaced
4
replaced lemborexant
4
lemborexant dose
4
low-dose
1
receptor
1
agonists
1

Similar Publications

When a difficult airway is anticipated, awake tracheal intubation can be considered. Usually, low doses of sedatives are administered during this procedure for minimal sedation and anxiolysis, such as midazolam and remifentanil. The newly developed ultra-short-acting benzodiazepine remimazolam has a pharmacokinetic profile that is more suitable for titration during awake tracheal intubation than the long-acting midazolam.

View Article and Find Full Text PDF

Co-occurring substance use disorders are common in medical settings, yet limited literature exists on concomitant pharmacological management. We present a case where low-dose buprenorphine induction (LDBI) and rapid phenobarbital taper were performed concurrently in a hospital setting to manage co-occurring opioid dependence (on chronic methadone maintenance therapy) and benzodiazepine dependence (prescribed alprazolam). The simultaneous management was well-tolerated and completed with minimal complications, successfully enabling candidacy for the patient's preferred disposition.

View Article and Find Full Text PDF

Appropriateness of Prescribing Transmucosal Immediate-Release Fentanyl in the Emergency Room, During Hospitalization, and at Discharge: A Retrospective Study.

Pharmaceuticals (Basel)

November 2024

Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, School of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.

: This study evaluated the appropriateness of transmucosal immediate-release fentanyl (TIRF) prescriptions in a Madrid emergency room during 2019 and 2022, following a 2018 warning about off-label use. : TIRF prescription in the emergency room search yielded 993 patients in 2019 and 1499 in 2022, of which 140 were randomized for the study, 70 in 2019, and 70 in 2022. Dose appropriateness and indication for TIRF were analyzed according to established criteria.

View Article and Find Full Text PDF

Introduction: Opioids and benzodiazepines are commonly prescribed for cancer symptoms. In combination, they can increase the risk of adverse events, particularly for older adults with multimorbidity, who represent most patients with cancer. We aimed to understand cancer care providers' practices for opioid and benzodiazepine coprescribing and mitigating potential harms.

View Article and Find Full Text PDF

Reassessing mirtazapine and akathisia: A case report on its efficacy in treating severe, treatment-resistant akathisia and a review of the evidence.

SAGE Open Med Case Rep

November 2024

Department of Psychiatry, London Health Sciences Centre, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.

Article Synopsis
  • * A 44-year-old man experienced severe, treatment-resistant akathisia from haloperidol, and standard treatments like benzodiazepines and benztropine were ineffective, leaving him in considerable distress.
  • * Introducing mirtazapine at a low dose successfully improved his symptoms, as shown by a significant drop in the Barnes Akathisia Rating Scale score, showcasing mirtazapine's potential as an effective treatment for resistant cases of akathisia.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!